The largest insider buys this week were in The Home Depot Inc. (HD, Financial), Humana Inc. (HUM, Financial), Union Pacific Corp. (UNP, Financial) and AbbVie Inc. (ABBV, Financial).
Home Depot director bought 1,120 shares
Director Linda R. Gooden bought 1,120 shares on Feb. 28 for an average price of $214.53. The share price has increased by 6.52% since then.
Home Depot is a home improvement retail company. The company operates big-box format stores across all 50 states, all 10 provinces in Canada and Mexico. The company has a market capitalization of $249.27 billion; as of March 6, it traded at $228.51.
On Feb. 25, Home Depot reported fourth-quarter and fiscal 2019 results. Sales for the quarter were $25.8 billion, a 5.2% increase from the prior-year quarter. Net earnings for the quarter were $2.5 billion, or $2.28 per diluted share, compared to net earnings of $2.3 billion, or $2.09 per diluted share, a year ago. Sales for fiscal 2019 were $110.2 billion, compared to sales of $108.2 billion during fiscal 2018.
Humana segment president, home business bought 1,785 shares
Segment President, Home Business Susan M. Diamond bought 1,785 shares on Feb. 28 at the average price of $319.68. The stock has increased by 14.81% since then.
Humana is an American for-profit health insurance company that was ranked number 56 on the Fortune 500 list in 2018. The company has a market capitalization of $48.49 billion; as of March 6, it traded at $367.01.
On Feb. 20, Humana announced the board of directors declared a quarterly dividend of 62.5 cents per share on the company’s common stock. The dividend will be payable on April 24 to shareholders of record at the close of business on March 31.
Union Pacific chief operating officer bought 3,206 shares
Chief Operating Officer Vincenzo J. Vena bought 3,206 shares on Feb. 28 for an average price of $155.92. The share price has increased by 0.11% since then.
Union Pacific is an American railroad holding company mainly serving the Western and Midwestern regions of the United States. The company has a market capitalization of $107.74 billion; as of March 6, it traded at $156.09.
On Feb. 6, Union Pacific announced the board of directors has declared a quarterly dividend of 97 cents per share on the company’s common stock, payable on March 31 to shareholders of record on Feb. 28. The company has paid dividends on its common stock for 121 consecutive years.
AbbVie director bought 2,875 shares
Director Edward J. Rapp bought 2,875 shares on March 3 for an average price of $87.87. The stock has gained 1.08% since then.
AbbVie is an American pharmaceutical company that focuses on discovering, developing and marketing both biopharmaceuticals and small molecule drugs. The company was created in 2013 as a spinoff of Abbott Laboratories. The company has a market capitalization of $131.38 billion; as of March 6, it traded at $88.82.
On March 3, AbbVie announced the European Commission has approved the divestiture of brazikumab, an investigational IL-23 inhibitor in development for autoimmune diseases, to AstraZeneca. The European Commission’s approval of AbbVie’s acquisition of Allergan in January of 2020 was conditional upon the divestiture of the drug to a suitable purchaser. The transaction will remain subject to additional customary closing conditions, but the final approval clears the pathway in Europe to close the transaction.
For the complete list of stocks that were bought by their company executives, go to Insider Trades.
Disclosure: I do not own stock in any of the companies mentioned in the article.
Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.
